Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 36 (10), 1145-9

An Improved Chromogenic Substrate Endotoxin Assay for Clinical Use

An Improved Chromogenic Substrate Endotoxin Assay for Clinical Use

R I Harris et al. J Clin Pathol.


An improved quantitative assay for endotoxin in plasma was developed after evaluating three different chromogenic substrates and seven methods for removal of plasma inhibitors. Optimal storage conditions for plasma samples prior to assay were also determined. Using chromogenic substrate S2423 with plasma diluted 1/10 in water and heated to 75 degrees C for 5 min to remove inhibitors, a within-batch coefficient of variation of 4% was obtained at levels of endotoxin likely to be encountered clinically. The limit of assay sensitivity was less than 10 pg/ml. This assay provides a sensitive quantitative test for single episodes of endotoxaemia in individual patients but variable activation of the Limulus proenzyme by endotoxin from different bacterial strains limits quantitative comparisons between patients.

Similar articles

See all similar articles

Cited by 16 PubMed Central articles

See all "Cited by" articles


    1. Lancet. 1974 Mar 30;1(7857):521-4 - PubMed
    1. Proc Soc Exp Biol Med. 1971 May;137(1):334-40 - PubMed
    1. J Clin Invest. 1972 Jul;51(7):1790-7 - PubMed
    1. Ann N Y Acad Sci. 1966 Jun 30;133(2):644-62 - PubMed
    1. Scand J Gastroenterol. 1976;11(8):857-63 - PubMed

Publication types

LinkOut - more resources